BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35846801)

  • 21. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
    Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
    Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - Imaging Analysis of 50 Consecutive Patients.
    Yadav T; Tiwari S; Gupta A; Garg PK; Khera PS; Rajagopal R; Goyal A; Soni K; Chugh A; Jain V; Sureka B; Elhence P; Misra S
    Curr Probl Diagn Radiol; 2022; 51(1):112-120. PubMed ID: 34802841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of histopathology in severity assessments of post-COVID-19 rhino-orbital cerebral mucormycosis - A case-control study.
    Shanmugasundaram S; Ramasamy V; Shiguru S
    Ann Diagn Pathol; 2023 Dec; 67():152183. PubMed ID: 37696132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
    Singh S; Basera P; Anand A; Ozair A
    Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
    Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
    Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
    Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
    J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Study of Clinical Profile of Patients With Mucormycosis During COVID-19 Pandemic in Tertiary Care Hospital.
    Kumar S; Anita ; Dev A; Kumar A; Kumar Nayan S; Singh S
    Cureus; 2023 Oct; 15(10):e47065. PubMed ID: 38021649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic.
    Fouad YA; Abdelaziz TT; Askoura A; Saleh MI; Mahmoud MS; Ashour DM; Ashour MM
    Front Med (Lausanne); 2021; 8():645270. PubMed ID: 34124087
    [No Abstract]   [Full Text] [Related]  

  • 32. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
    Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
    J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sinonasal and Orbital Imaging Findings in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of COVID-19: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Kumbhalkar S; Selvi K; G D; Bidkar V; Dabhekar S; Prathipati K; Sawal A
    Cureus; 2023 Jul; 15(7):e42674. PubMed ID: 37649953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
    Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
    Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhino Orbital Cerebral Mucormycosis in Covid-19 Crisis.
    Vadivel S; Gowrishankar M; Vetrivel K; Sujatha B; Navaneethan P
    Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):1014-1020. PubMed ID: 36855632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging findings in invasive rhino-orbito-cerebral mucormycosis in post-COVID-19 patients.
    Jindal G; Sethi A; Bhargarva K; Sethi S; Mittal A; Singh U; Singh S; Shrivastava A
    Proc (Bayl Univ Med Cent); 2022; 35(1):32-34. PubMed ID: 34970028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.